940 KRW
40.20 B KRW
859.63 B KRW
11.96 M
About BORYUNG PHARM
Sector
Headquarters
Seoul
Founded
1963
Website
ISIN
KR7003850005
FIGI
BBG000BGY7K6
Boryung Corp. engages in the manufacture, sales, and distribution of products related to pharmaceuticals and biotechnology. It offers products for hypertension and dyslipidemia, Oncology, specialty care, diabetes, renal, Central Nervous System (CNS), and over-the-counter (OTC). The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 003850 is 10,310 KRW — it has increased by 2.15% in the past 24 hours. Watch BORYUNG PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BORYUNG PHARM stocks are traded under the ticker 003850.
003850 stock has risen by 0.68% compared to the previous week, the month change is a 1.66% rise, over the last year BORYUNG PHARM has showed a −12.63% decrease.
We've gathered analysts' opinions on BORYUNG PHARM future price: according to them, 003850 price has a max estimate of 15,000.00 KRW and a min estimate of 15,000.00 KRW. Watch 003850 chart and read a more detailed BORYUNG PHARM stock forecast: see what analysts think of BORYUNG PHARM and suggest that you do with its stocks.
003850 reached its all-time high on Jan 12, 2021 with the price of 24,600 KRW, and its all-time low was 370 KRW and was reached on Jun 24, 2004. View more price dynamics on 003850 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
003850 stock is 2.53% volatile and has beta coefficient of 0.65. Track BORYUNG PHARM stock price on the chart and check out the list of the most volatile stocks — is BORYUNG PHARM there?
Today BORYUNG PHARM has the market capitalization of 876.57 B, it has decreased by −3.95% over the last week.
Yes, you can track BORYUNG PHARM financials in yearly and quarterly reports right on TradingView.
BORYUNG PHARM revenue for the last quarter amounts to 260.40 B KRW, despite the estimated figure of 260.40 B KRW. In the next quarter, revenue is expected to reach 292.40 B KRW.
003850 net income for the last quarter is 9.35 B KRW, while the quarter before that showed 23.64 B KRW of net income which accounts for −60.44% change. Track more BORYUNG PHARM financial stats to get the full picture.
Yes, 003850 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 0.96%. Tracking BORYUNG PHARM dividends might help you take more informed decisions.
BORYUNG PHARM dividend yield was 0.84% in 2023, and payout ratio reached 16.38%. The year before the numbers were 1.10% and 15.73% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 1.59 K employees. See our rating of the largest employees — is BORYUNG PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BORYUNG PHARM EBITDA is 113.22 B KRW, and current EBITDA margin is 13.04%. See more stats in BORYUNG PHARM financial statements.
Like other stocks, 003850 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BORYUNG PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BORYUNG PHARM technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BORYUNG PHARM stock shows the sell signal. See more of BORYUNG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.